radioligand therapy

You have access
The Potential Contribution of Radiopharmaceutical Therapies in Managing Oligometastatic Disease
Amar U. Kishan, Shankar Siva, Michael S. Hofman, James Nagarajah, Ana P. Kiess, Phuoc Tran and Jeremie Calais

Journal of Nuclear Medicine April 1, 2024, 65 (4) 502-509; DOI: https://doi.org/10.2967/jnumed.123.266772
You have access
First Safety and Efficacy Data with the Radiohybrid ¹⁷⁷Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
Alexander Dierks, Alexander Gäble, Andreas Rinscheid, Georgine Wienand, Christian H. Pfob, Malte Kircher, Johanna S. Enke, Tilman Janzen, Marianne Patt, Martin Trepel, Dorothea Weckermann, Ralph A. Bundschuh and Constantin Lapa

Journal of Nuclear Medicine March 1, 2024, 65 (3) 432-437; DOI: https://doi.org/10.2967/jnumed.123.266741
Open Access
Renal and Multiorgan Safety of ¹⁷⁷Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
Ken Herrmann, Kambiz Rahbar, Matthias Eiber, Richard Sparks, Nicholas Baca, Bernd J. Krause, Michael Lassmann, Walter Jentzen, Jun Tang, Daniela Chicco, Patrick Klein, Lars Blumenstein, Jean-René Basque and Jens Kurth

Journal of Nuclear Medicine January 1, 2024, 65 (1) 71-78; DOI: https://doi.org/10.2967/jnumed.123.265448
You have access
Long-Term Nephrotoxicity of ¹⁷⁷Lu-PSMA Radioligand Therapy
Lisa Steinhelfer, Lukas Lunger, Lisena Cala, Christian H. Pfob, Constantin Lapa, Philipp E. Hartrampf, Andreas K. Buck, Hannah Schäfer, Christoph Schmaderer, Robert Tauber, Julia Brosch-Lenz, Bernhard Haller, Valentin H. Meissner, Karina Knorr, Wolfgang A. Weber and Matthias Eiber

Journal of Nuclear Medicine January 1, 2024, 65 (1) 79-84; DOI: https://doi.org/10.2967/jnumed.123.265986
You have access
An Intrapatient Dosimetry Comparison of ¹⁷⁷Lu-rhPSMA-10.1 and ¹⁷⁷Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Andreas Rinscheid, Alexander Gäble, Georgine Wienand, Christian Pfob, Alexander Dierks, Malte Kircher, Martin Trepel, Dorothea Weckermann, Constantin Lapa and Ralph A. Bundschuh

Journal of Nuclear Medicine December 1, 2023, 64 (12) 1918-1924; DOI: https://doi.org/10.2967/jnumed.123.265970
You have access
Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with ¹⁷⁷Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis
Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin and Jeremie Calais

Journal of Nuclear Medicine November 1, 2023, 64 (11) 1737-1743; DOI: https://doi.org/10.2967/jnumed.122.265155
You have access
[¹⁷⁷Lu]Lu-PSMA-617 Therapy in a Patient with Chronic Kidney Disease
Lorenzo Mercolli, Clemens Mingels, Giulia Manzini, Paul Cumming, Konstantinos Zeimpekis, Song Xue, Ian Alberts, Dominik Uehlinger, Axel Rominger, Kuangyu Shi and Ali Afshar-Oromieh

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1570-1573; DOI: https://doi.org/10.2967/jnumed.123.265577
You have access
Albumin-Binding and Conventional PSMA Ligands in Combination with ¹⁶¹Tb: Biodistribution, Dosimetry, and Preclinical Therapy
Viviane J. Tschan, Sarah D. Busslinger, Peter Bernhardt, Pascal V. Grundler, Jan Rijn Zeevaart, Ulli Köster, Nicholas P. van der Meulen, Roger Schibli and Cristina Müller

Journal of Nuclear Medicine October 1, 2023, 64 (10) 1625-1631; DOI: https://doi.org/10.2967/jnumed.123.265524
Open Access
Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy
Yizhen Pang, Liang Zhao, Jianyang Fang, Jianhao Chen, Lingxin Meng, Long Sun, Hua Wu, Zhide Guo, Qin Lin and Haojun Chen

Journal of Nuclear Medicine September 1, 2023, 64 (9) 1449-1455; DOI: https://doi.org/10.2967/jnumed.123.265599
You have access
Safety and Efficacy of [¹⁷⁷Lu]-PSMA-I&T Radioligand Therapy in Octogenarians with Metastatic Castration-Resistant Prostate Cancer: Report on 80 Patients over the Age of 80 Years
Robert Tauber, Karina Knorr, Margitta Retz, Isabel Rauscher, Sonia Grigorascu, Kimberley Hansen, Calogero D’Alessandria, Hans-Jürgen Wester, Jürgen Gschwend, Wolfgang Weber, Matthias Eiber and Thomas Langbein

Journal of Nuclear Medicine August 1, 2023, 64 (8) 1244-1251; DOI: https://doi.org/10.2967/jnumed.122.265259

Main menu

User menu

Search

radioligand therapy

Pages